Publish with Us

GenoMed Connect

Hanieh Yaghootkar
Editor-in-Chief

Hanieh Yaghootkar
Editor-in-Chief

View Profile

GenoMed Connect facilitates interdisciplinary collaboration in advancing genomic integration into medicine. We welcome diverse contributions covering genomic medicine, translational genomics, precision medicine, human genetics, microbial genomics, technological advances, and ethical/social implications.  This open-access journal follows a continuous publication model and is licensed under Creative Commons Attribution 4.0 (CC BY 4.0).

Volumes 2
Articles 17
Volume: 2, 2025

Insights

42 Days

Time to First Peer Review Decision

75 Days

Time to Final Acceptance

6 Days

Acceptance to First Online


Recent Articles

Research Article

Available Online: 09 Dec 2025

AI-Driven Machine Learning Analysis Among Major Depression: Sex-Based Variations in Oxytocin and Clinical Profiles

Volume 2

Background: Major depressive disorder (MDD) has significant sex-specific changes in psychiatric manifestation, biologic, and clinical response to treatment. The current breakthroughs in machine learning and artificial intelligence (AI) provide novel possibilities to approach multidimensional, multifaceted datasets in psychoanalytic studies. Nevertheless, gender, oxytocin, inflammatory biomarkers, and clinical characteristics of MDD are not studied in detail, especially among people in the Middle..

Editorial

Published: 03 Oct 2025

Current Insights into Pharmacogenomics of Noncoding RNAs for Cancer Therapy

Volume 2

Cancer remains a significant global health challenge, with varying incidence and mortality rates across the globe. According to the Surveillance, Epidemiology, and End Results (SEER) registry [1] and the American Cancer Society (ACS) [2], more than 2 million new cancer cases are expected in the US by 2025. Understanding the burden of disease and advancements in tailored treatments, also known..

Review Article

Published: 24 Jun 2025

Epigenetic Insights into Bladder Cancer: The Role of Urine DNA Methylation Assays: Mini Review

Volume 2

Bladder cancer remains a major global health challenge due to its high incidence, recurrence rates, and reliance on invasive diagnostic procedures. While conventional methods, such as cystoscopy and urine cytology, are considered standard, they often demonstrate limited sensitivity, particularly in detecting early-stage disease. Epigenetic alterations, particularly DNA methylation, are now recognized as critical in bladder cancer development and progression. Non-invasive..

Research Article

Published: 23 Jun 2025

Clinical Diversity and Outcomes of Progressive Familial Intrahepatic Cholestasis Diagnosed by Whole Genome Sequencing in Pakistani Children

Volume 2

Progressive familial intrahepatic cholestasis (PFIC) is a rare group of genetic disorders that typically presents in infants and children, often progressing to end-stage liver disease. We used whole genome sequencing (WGS) for diagnosis to assess phenotypic features and outcomes in Pakistani children with different types of PFIC. The study included 116 pediatric participants with five PFIC types: PFIC1, ATP8B1 gene..